Kidney Replacement Therapy for Chronic Kidney Disease: Evidence-based Guidelines for Clinical Practice

Author:

George Reena1,Priyadharshini Hilda Mercy2,Paul David Sam3

Affiliation:

1. Professor, College of Nursing, CMC, Vellore, Tamil Nadu, India

2. Assistant Professor, College of Nursing, CMC, Vellore, Tamil Nadu, India

3. Tutor, College of Nursing, CMC, Vellore, Tamil Nadu, India

Abstract

Abstract As chronic kidney disease progresses to end-stage kidney disease, therapies such as haemodialysis, peritoneal dialysis or kidney transplantation will be required to sustain the life of patients, which are referred to as kidney replacement therapies (KRTs). Each modality of replacement therapy has its benefits and risks which should be communicated to the patients and family members before the end stage of kidney disease so that patients may be guided to make informed choice of treatment. Those who are not willing or suitable for KRT may be provided conservative kidney management. This article discusses about the KRT options available in management of end-stage kidney disease, highlighting the indications, principles, guidelines for clinical practice, benefits and risks of each of these modalities which will direct the nurses in providing comprehensive, evidence-based nursing care to patients receiving replacement therapies.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3